Faculty Articles

Title

What Are We Treating With Antihyperglycaemic Drug Therapy?

ISBN or ISSN

1759-8893

Publication Title

Journal of Pharmaceutical Health Services Research

Volume

9

Issue

3

Publication Date / Copyright Date

9-2018

First Page

173

Last Page

174

Publisher

Oxford Academic

DOI Number

10.1111/jphs.12260

Abstract

Excerpt

Diabetes produces one of the biggest economic and health burdens in the United States. The total estimated cost of diabetes in 2017 was $327 billion, an increase of 26% when compared to 2012.[1] Cardiovascular and chronic kidney disease and death are major complications of type 2 diabetes.[2] Specifically, cardiovascular disease is currently one of the leading causes of morbidity and mortality in this population and the largest contributor to the direct and indirect costs of diabetes.[2,3] At least 68% of people aged 65 or older with diabetes die from some form of heart disease.[3] Furthermore, diabetes is the seventh leading cause of death in the United States.

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Keywords

cardiovascular disease, diabetes, economics, health, kidney disease, older adults, United States

Peer Reviewed

Find in your library

Share

 
COinS